Evaluation of a Prognostic Epigenetic Classification System in Chronic Lymphocytic Leukemia Patients.
Christina GrimmCarmen Diana HerlingAnastasia KomnidiMichelle HussongKarl-Anton KreuzerMichael HallekMichal R SchweigerPublished in: Biomarker insights (2022)
= .0008). In addition, when comparing the prognostic value of the epigenetic classification system with the IGHV classification, epigenetic grouping performed better compared to IGHV mutational status using Kaplan-Meier estimation and allowed the identification of a third, intermediate (i-CLL) group. Thus, our study confirmed the prognostic value of the epigenetic marker set for patient stratification in routine clinical diagnostics.